Literature DB >> 1316470

Structural and functional analysis of the visna virus Rev-response element.

L S Tiley1, B R Cullen.   

Abstract

The distantly related lentiviruses human immunodeficiency virus type 1 (HIV-1) and visna virus each encode a posttranscriptional regulatory protein, termed Rev, that is critical for expression of the viral structural proteins. We genetically mapped the cis-acting target sequence for visna virus Rev, the visna virus Rev-response element or RRE-V, to a complex 176-nucleotide RNA stem-loop structure that coincides with sequences encoding the N terminus of the transmembrane component of envelope. The computer-predicted structure of the RRE-V was validated by in vitro analysis of structure-specific RNase cleavage patterns. The visna virus Rev protein was shown to interact specifically with the genetically defined RRE-V in vitro but was unable to bind the HIV-1 RRE. Similarly, HIV-1 Rev was also unable to bind the RRE-V specifically. We therefore conclude that the HIV-1 and visna virus Rev proteins, while functionally analogous, nevertheless display distinct RNA sequence specificities. These findings provide a biochemical explanation for the observation that these two viral regulatory proteins are functional only in the homologous viral system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316470      PMCID: PMC241143     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency.

Authors:  M H Malim; B R Cullen
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

2.  Rev-dependent expression of human immunodeficiency virus type 1 gp160 in Drosophila melanogaster cells.

Authors:  M Ivey-Hoyle; M Rosenberg
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

3.  Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif.

Authors:  M L Zapp; T J Hope; T G Parslow; M R Green
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

4.  Identification of feline immunodeficiency virus rev gene activity.

Authors:  T Kiyomasu; T Miyazawa; T Furuya; R Shibata; H Sakai; J Sakuragi; M Fukasawa; N Maki; A Hasegawa; T Mikami
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein.

Authors:  L S Tiley; M H Malim; H K Tewary; P G Stockley; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

6.  Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif.

Authors:  T J Hope; B L Bond; D McDonald; N P Klein; T G Parslow
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev.

Authors:  J Kjems; A D Frankel; P A Sharp
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

8.  Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element.

Authors:  J Kjems; M Brown; D D Chang; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

Review 9.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

Authors:  A S Fauci
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

10.  Visna virus exhibits a complex transcriptional pattern: one aspect of gene expression shared with the acquired immunodeficiency syndrome retrovirus.

Authors:  J L Davis; S Molineaux; J E Clements
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

View more
  11 in total

1.  An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein.

Authors:  J Yang; H P Bogerd; S Peng; H Wiegand; R Truant; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 2.  Mechanism of action of regulatory proteins encoded by complex retroviruses.

Authors:  B R Cullen
Journal:  Microbiol Rev       Date:  1992-09

3.  Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology.

Authors:  Sheila A Barber; Linda Bruett; Brian R Douglass; David S Herbst; M Christine Zink; Janice E Clements
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  The human endogenous retrovirus K Rev response element coincides with a predicted RNA folding region.

Authors:  J Yang; H Bogerd; S Y Le; B R Cullen
Journal:  RNA       Date:  2000-11       Impact factor: 4.942

5.  Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.

Authors:  C Leroux; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Structural and functional analysis of the avian leukemia virus constitutive transport element.

Authors:  J Yang; B R Cullen
Journal:  RNA       Date:  1999-12       Impact factor: 4.942

7.  Identification of the activation domain of equine infectious anemia virus rev.

Authors:  R A Fridell; K M Partin; S Carpenter; B R Cullen
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

8.  Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing.

Authors:  L Martarano; R Stephens; N Rice; D Derse
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

Review 9.  The genome of feline immunodeficiency virus.

Authors:  T Miyazawa; K Tomonaga; Y Kawaguchi; T Mikami
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Analysis of the EIAV Rev-responsive element (RRE) reveals a conserved RNA motif required for high affinity Rev binding in both HIV-1 and EIAV.

Authors:  Jae-Hyung Lee; Gloria Culver; Susan Carpenter; Drena Dobbs
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.